(Reuters) - Canada's health department said on Wednesday that it has updated the product label for AstraZeneca Plc's COVID-19 vaccine to provide information on "very rare reports of blood clots associated with low levels of blood platelets." Read full story
http://dlvr.it/RwLXpN
No comments:
Post a Comment